MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • MDS Virtual Congress 2020

    Impairment of the mesocortical dopamine system in Parkinson’s disease patients with freezing of gait in a multimodal imaging approach

    K. Steidel, M. Ruppert, A. Greuel, I. Palaghia, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

    Objective: To investigate the involvement of dopaminergic systems in Parkinson’s disease (PD) patients with freezing of gait (FOG) using a multimodal assessment involving 18 F-DOPA-PET…
  • MDS Virtual Congress 2020

    Right hemispheric β-amyloid deposition associates with freezing of gait in Parkinson’s disease

    P. Kanel, M. Müller, K. Frey, N. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate regional cerebral deposition of β-amyloid in patients with Parkinson's disease (PD) who have freezing of gait (FoG). Background: FoG is one of…
  • MDS Virtual Congress 2020

    Neuroimaging Extra-Striatal D2 Receptors in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

    M. Valli, SS. Cho, M. Masellis, R. Chen, Y. Koshimori, M. Diez-Cirarda, A. Mihaescu, A. Strafella (Toronto, ON, Canada)

    Objective: Our aim was to characterize the extra-striatal dopamine in Parkinson’s disease (PD) with and without rapid eye movement sleep behaviour disorder (RBD) using in…
  • MDS Virtual Congress 2020

    Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study

    M. Kinnerup, C. Doppler, E. Farrher, T. Fedorova, J. Schaldemose, K. Knudsen, R. Isamail, A. Hansen, K. Stær, G. Fink, J. Shah, D. Brooks, A. Nahimi, P. Borghammer, M. Sommerauer (Aarhus, Denmark)

    Objective: To assess multimodal imaging of the noradrenergic system: magnetic resonance imaging (MRI) neuromelanin contrast of the locus coeruleus (LC) and noradrenalin transporter density with…
  • MDS Virtual Congress 2020

    Decreased Availability of Adenosine 2A Receptors in the Caudate in Patients with Early Stage Parkinson’s Disease

    I. Waggan, E. Rissanen, J. Tuisku, J. Joutsa, S. Helin, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

    Objective: The aim of this study was to investigate Adenosine 2A (A2A) receptor availability in patients with early and moderate stage Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2020

    Association between motor symptoms and striatal VMAT2 binding in PD: a PET study

    S.Y Liu, H.W Qiao, C.Y Qi, Z.Q Gu, O. Barret, K. Marek, G. Tamagnan, P. Chan (Beijing, China)

    Objective: In this study, we investigate the association between motor symptoms and striatal vesicular monoamine transporter type 2 (VMAT2) binding using 18F-FP-DTBZ PET in PD…
  • MDS Virtual Congress 2020

    Reduced Striatal VMAT2 in REM Sleep Behavior Disorder: A Gateway to Preclinical Parkinson’s Disease

    K. Barnham, L. Beauchamp, V. Villemagne, D. Finnkelstein, V. Dore, A. Bush, C. Rowe (Melbourne, Australia)

    Objective: To determine the degree of striatal degeneration that occurs in subjects with REM Sleep Behavior Disorder (RBD) and assess whether this is an appropriate…
  • MDS Virtual Congress 2020

    Visualization of Nigrosome 1 at 3T MRI and 18F-DOPA PET for the diagnosis of Parkinson´s disease

    A. Martin-Bastida, V. Suarez-Vega, P. Dominguez-Echavarri, F. Guillen-Valderrama, I. Aviles-Olmos, J. Arbizu, M. Rodriguez-Oroz (Pamplona, Spain)

    Objective: To determine and compare the utility of Nigrosome 1 at 3T MRI and 18F-DOPA PET for the diagnosis of Parkinson´s disease. Background: Differential diagnosis…
  • MDS Virtual Congress 2020

    Premotor compensatory mechanisms in Parkinson’s disease with LRRK2-R1441H mutation

    S. Sambin, S. Lavisse, C. Decaix, G. Mangone, F. Cormier, B. Le Toullec, S. Lesage, P. Remy, A. Brice, J.C Corvol (Paris, France)

    Objective: To investigate the time course of modifications in dopaminergic terminals during the premotor phase in LRRK2 genetically determined Parkinson’s disease (PD). Background: Increased dopamine…
  • MDS Virtual Congress 2020

    Graph theory analysis of dopamine D2 receptor network in Parkinson’s disease patients

    A. Mihaescu, J. Kim, S. Cho, M. Diez-Cirarda, M. Valli, Y. Koshimori, A. Strafella (Toronto, ON, Canada)

    Objective: The aim of this study was to explore a novel method of analyzing positron emission tomography (PET) data using graph theory analysis. To this…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley